• Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
TheraCryf
  • Science
  • Pipeline
  • About Us
  • News & Media
  • Resources
  • Investors
  • Contact Us
Mobile close button Mobile toggle button

Notice of AGM

mel | 20 June 2023
Categories:

Post navigation

← SFX-01 in the treatment of rhabdomyosarcoma: Preclinical results in cellular models
Voting on AGM Resolutions →
footer logo
Copyright© 2025
ICO Reg: ZB396415
Company Number: 09246681
  • Website Privacy Policy and Cookie Policy
  • Sitemap
Twitter Twitter linkedin linkedin
Get in touch